Assessing Arm's Impending IPO Valuation: A Discourse on SoftBank's Strategy and Market Realities

 The impending public listing of chip designer Arm, anticipated to be the largest such offering in the United States this year, has been accompanied by a surge in interest within the artificial intelligence sector, benefiting its peers in the chip stock domain. The notable participation of key clientele in the initial public offering, coupled with the enlistment of an extensive consortium of financial institutions, prompts inquiry into the motives driving Arm's parent company, SoftBank, to adopt such a comprehensive strategy.

The consortium overseeing the IPO comprises prominent financial entities including Barclays, Goldman Sachs, JPMorgan, and Mizuho, in addition to twenty-four other underwriters. While this assemblage stands to derive benefits from this endeavor, particularly in a market environment marked by a scarcity of IPO transactions leading to record low deal proceeds last year, the magnitude of this group conveys a tacit acknowledgment of SoftBank's necessity for external support to achieve its objectives.

Forecasts point to Arm seeking an valuation ranging from $60 billion to $70 billion, a valuation spectrum that, if attained, holds potential to ameliorate the adverse impact of the Vision Fund's unprecedented $30 billion loss endured in the prior year. SoftBank has strategically orchestrated conditions conducive to securing an elevated valuation. Notably, the listing document discloses an intra-company transaction through which SoftBank acquired the Vision Fund's stake in Arm for $16 billion, a transaction underpinning a valuation for the chip manufacturer surpassing $64 billion.

It is prudent for investors to exercise a degree of circumspection regarding this valuation assertion. From the vantage point of a broader, industry-standard earnings multiple, the enterprise value attributed to Arm is more aptly situated at approximately $30 billion. This valuation aligns closely with the price SoftBank initially paid when it procured Arm in 2016.

Despite endeavors to position Arm as an entity thriving within the AI sector, it would be imprudent to conflate its valuation with that of Nvidia, a preeminent AI chip manufacturer. While AI chip sales are enjoying a surge, Arm's financial performance witnessed a contraction during the preceding fiscal year, with its fortunes more intimately linked to the smartphone market—a sector that has been grappling with stagnation since 2016.

The primary existential threat to Arm's valuation emanates from China. Impediments imposed by export controls levied by the United States and the United Kingdom have cast a shadow over revenues garnered from China, which constitute nearly one-fourth of the company's overall earnings. Compounding these concerns, Chinese firms have displayed assertive investment pursuits in the development of the RISC-V architecture—a chip design framework rooted in open-source principles—that stands as a prospective alternative to Arm's proprietary designs.

Historical instances of valuation disparities between SoftBank and prevailing market trends are by no means anomalous. The case of WeWork underscores the consistent perturbation experienced by shareholders as a result of SoftBank's periodic revaluations of its portfolio. The diminution of SoftBank's share value by over a third from its peak in 2021 necessitates attention. Masayoshi Son, the Chief Executive, contends that the company is undervalued relative to its net asset value. However, Son's embellished assessment of Arm's valuation casts doubt on the veracity of his assertion.